March 02, 2015 11:13 PM ET


Company Overview of Edge Therapeutics, Inc.

Executive Profile

Charles Prestigiacomo M.D.

Member of the Scientific Advisory Board, Edge Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Charles Prestigiacomo MD serves as an Advisor of Micrus Endovascular Corporation. Dr. Prestigiacomo serves as Director of the Neurological Surgery Residency Program, Neurological Institute of New Jersey, University of Medicine & Dentistry of New Jersey. Dr. Prestigiacomo has been a Member of the Scientific Advisory Board at Edge Therapeutics, Inc. since June 2010. Dr. Prestigiacomo is Assistant Professor of Department of Neurological Surgery and Radiology, Neurological ...

Corporate Headquarters

139 South Street
New Providence, New Jersey 07974

United States

Phone: 800-208-3343
Fax: 800-208-3433

Board Members Memberships

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Edge Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at